Stryker settles $1.35 million case claiming it pushed unsafe bone treatments
A leading manufacturer of artificial hips and knees agreed to pay the state of Massachusetts $1.35 million to resolve allegations that it marketed orthopedic devices without regulatory approval and, to boost sales, withheld patient safety information from health care providers.
A complaint filed earlier this month by Massachusetts Attorney General Martha Oakley accused Stryker Biotech, a unit of the Stryker Corporation, of falsifying hospital review documents, subverting clinical review procedures, promoting the use of medical devices not approved by the FDA, and misleading physicians about appropriate use of its products.
